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Abstract.  We have previously described a variant 
form of the integrin/31  subunit (/JIB)m characterized 
by an altered sequence at the cytoplasmic domain. 
Using polyclonal antibodies to a  synthetic peptide cor- 
responding to the unique sequence of the/3 IB,  we ana- 
lyzed the expression of this molecule in human tissues 
and cultured cells. Western blot analysis showed that 
the/JIB is expressed in skin and liver and,  in lower 
amounts,  in skeletal and cardiac muscles.  The protein 
was not detectable in brain,  kidney, and smooth mus- 
cle.  In vitro cultured keratinocytes and hepatoma cells 
are positive, but fibroblasts, endothelial cells, and 
smooth muscle cells are negative.  An astrocytoma cell 
line derived from immortalized fetal astrocytes was 
found to express/JIB. In these cells/JIB represent 
,x,30%  of the 131 and form heterodimers with txl  and 
or5 subunits.  To investigate the functional properties of 
/JIB,  the full-length eDNA coding for this molecule was 
transfected  into  CHO  cells.  Stable  transfectants  were 
selected and the/JIB was identified by a mAb that dis- 
criminate between the transfected human protein and 
the endogenous hamster/JlA.  Immunoprecipitation ex- 
periments indicated that the/JIB was exported at the cell 
surface in association with the endogenous hamster o~ 
subunits.  The ot5//jIB complex bound to a fibronectin- 
affinity matrix and was specifically released by RGD- 
"containing peptides.  Thus/JIB and/JlA are similar as 
far as the tx//J association and fibronectin binding are 
concerned.  The two proteins differ,  however, in their 
subcellular localization.  Immunofluorescence studies 
indicated,  in fact, that/JIB,  in contrast to/JlA,  does 
not localize in focal adhesions.  The restricted tissue 
distribution and the distinct subcellular localization, 
suggest that/JIB has unique functional properties. 
I 
NTEGRINS are a large family of heterodimeric membrane 
receptors involved in cell adhesion and recognition  in a 
variety of processes including embryogenesis, hemosta- 
sis, tissue repair, immune response, and metastatic diffusion 
of tumor  cells  (Hynes,  1987; Hemler,  1990;  Ruoslahti, 
1991). These molecules provide a link between extracellular 
structures and cytoskeletal components and transduce me- 
chanical  forces across  the plasma  membrane  during  cell 
adhesion and migration.  Both ot and/3 integrin subunits span 
the lipid bilayer and possess a large extracellular  and a short 
cytoplasmic domain  (Hynes,  1987; Hemler,  1990;  Ruos- 
lahti,  1991). The extracellular  domain mediates the interac- 
tion with matrix proteins.  Many of the known integrins bind 
the Arg-Gly-Asp (RGD in one letter code) sequence present 
in  several  extracellular  matrix  proteins  (Ruoslahti  and 
Pierschbacher,  1987) and representing  a recognition  signal 
of broad importance in cell adhesion.  Binding to the RGD 
sequence involves the extracellular  domains of both o~ and 
/3 subunit of the heterodimer and requires divalent cations. 
The cytoplasmic domain of integrins  interacts  with cyto- 
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skeletal  components and is required for the localization  of 
these membrane proteins at focal contact sites with the sub- 
stratum  (Hayashi,  1990;  Marcantonio,  1990).  These sites 
correspond to areas where actin microfilament  bundles are 
anchored to the plasma membrane via cytoskeletal compo- 
nents, such as vinculin,  talin, and o~-aetinin (Burridge et al., 
1988).  Experimental  evidence for binding  of the integrin 
complex to talin has been provided (Horwitz et al.,  1986). 
More recently binding  of ot-aetinin  to  synthetic  peptides 
reproducing  the cytoplasmic domain of the /31A  2 and/33 
subunit has also been reported (Otey et al., 1990), suggest- 
ing that these two cytoskeletal proteins may be responsible 
for bridging  integrins  to actin microfilament  bundles.  Vari- 
1. This/~1 variant was previously indicated as BI3~, (Altrnda, E, P. Cer- 
vella, G. Tarone, (7. Botta, F. Balzac, G. Stefanuto, and L. Silengo. 1990. 
Gene. 95:261-266).  For the sake of uniformity with other integrin variants 
this molecule is now indicated as/~IB to distinguish it from the classical 
form BIA (Argraves, S., S. Suzuki, H. Aria, K. Thompson, M. Piersch- 
bather, and E. Ruoslahti.  1987. J.  Cell BioL  105:1183-1190)  and from a 
second variant form/~IC (Languino, L. R., and E. Ruoslahti. 1992. J. Biol. 
Chem.  267:7116-7120). 
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the cytoplasmic domain have been described (van Kuppevelt 
et al., 1989; Altruda et al., 1990;  Languino and Ruoslahti, 
1992). In addition cytoplasmic domain variants of  the/34 and 
or6 subunits have also been identified (Tamura et al., 1990; 
Hogervorst et al., 1991; Tamura et al., 1991). The existence 
of such variants suggests diverse functions of the integrin cy- 
toplasmic domains. 
We have previously isolated the full length eDNA for a 
variant form of the integrin/31 subunit in which a unique 12- 
amino acid sequence replaces the last 21  COOH-terminal 
amino acids of the/31A (Altruda et al., 1990). To gain infor- 
mation on the functional significance of the/31B, we inves- 
tigated its expression in tissues and cultured cells and ana- 
lyzed its properties in CHO cell transfected with the human 
/31B full-length cDNA. 
Materials and Methods 
Ce//s 
CHO cells were grown in HAM F12 medium with 10% FCS.  The human 
astrocytoma cell line Aseh-7 was produced by immortalization  of human fe- 
tal astrocytes as described (Balabanov et al., 1990). Human skin fibroblasts, 
human umbilical vein endothelial cells,  and human keratinocytes  were 
kindly provided by Drs. O. Ornatsky, M. Frid, and M. Lukashev (Institute 
of  Experimental  Cardiology,  Moscow,  Russia).  Human  aortic  medial 
smooth muscle ceils were  isolated and cultured as described (Chamley- 
Campbell et al.,  1979). Human hepatoma cell line HepG-2  was from the 
American Type Culture Collection (Rockville,  MD). 
Constructs and Transfections 
A 3.5-kb EcoRI fragment of the/31B integrin (Altruda et al., 1990) contain- 
ing the entire coding sequence was inserted into the EcoRI cloning site of 
the SV-40-based  expression vector pECE (Ellis et al.,  1986).  The full- 
length eDNA for/31A cloned in the pECE vector was a kind gift of Filippo 
Giancotti,  New  York University,  New  York (Giancotti and  Ruoslahti, 
1990). CHO cells (106 cells/50-cm  2 plate) were co-transfected  with 20 tLg 
of the plasmid containing/31B  eDNA and 2 ~g of pSV2-neo (Southern and 
Berg, 1982) by the calcium phosphate precipitation method (Chen et al., 
1987). After 48 h the cells were split 1:10 and incubated with 800 #g/ml 
of (3418 (GIBCO BRL, Gaithersburg, MD) to select neomycin-resistant 
clones.  10 to 14 d Iater colonies of G418-resistant ceils were collected by 
scraping with micropipette tips and transferred to 24-well plates.  Colonies 
were  subsequently  maintained in complete medium with 400 t~g/ml of 
(3418. 
FACS Analysis 
For FACS analysis,  transfected cells were detached from culture plates by 
incubation in 5 mM EDTA in PBS (10 mM phosphate buffer, pH 7.3, 150 
mM sodium chloride) and washed twice at 4"C in PBS with 0.1 mM EDTA 
and 1 mg/ml of BSA. The cells were then incubated for 1 h at 4°C in the 
same buffer with the appropriate dilution of the AIA5 mAb to the human 
/31  integrin.  After  washing,  the  cells  were  incubated 45  rain  with  a 
fluorescein-labeled  affinity-purified secondary antibodies, and analyzed on 
the flow cytometer Facs-Star (Becton Dickinson & Co.,  Mountainview, 
CA) equipped with 5 W argon laser at 488 nm. 5,000 cells per sample were 
analyzed. 
Antibodies and Immunoprecipitation of  lntegrins 
The polyclonal antisera to the/31A and/31B subunits were prepared by im- 
munizing rabbits against synthetic peptides  reproducing amino acid  se- 
quences from the cytoplasmic domains specific for each subunit. The fol- 
lowing peptides,  obtained from Multiple Peptide System (San Diego, CA), 
were used:/31A, CTTVVNPKYEGK; and/3113, CSYKTSKKQSGL.  Pep- 
tides were coupled to bemocyanin with glutaraldehyde  (approximate  pep- 
tide/carrier molar ratio of 50:1) and rabbits were injected with 500 #g of 
the conjugate in complete Freund adjuvant.  Antibodies to cytoplasmic se- 
quences of the or3 and c~5 integrin subunits were previously  described and 
characterized (Defilippi et al., 1991). For Western blotting and immunopre- 
cipitation experiments the/31B antibodies were purified from the serum by 
affinity chromatography on/31B-albumin conjugate coupled to Sepharose. 
A polyclonal antibody to/33 was prepared in our laboratory by immunizing 
rabbits with/33 purified from human platelets as described (Defilippi et ai., 
199D. Mouse mAbs to human integrin ~xl (mAb TS2/7) and to integrin/31 
(mAb A1A5) were a kind gift from Dr. Martin Hemler (Dana-Farber Cancer 
Institute, Boston,  MA). mAb 102DF5 (Ylanne et al.,  1989) to human/31 
was a kind gift from Dr. Ismo Virtanen (University of Helsinki, Helsinki, 
Finland). 
The  mAb  A1A5 reacts  with human,  but  not  with hamster fll  and 
identifies an epitope in the extracellular domain which is common to both 
/31A and/3lB. 
Integrins were immunoprecipitated from cells either unlabeled or labeled 
with 125I. Labeling of membrane proteins with 12Sl was performed as de- 
scribed previously  (Rossino et al.,  1990). Briefly, cells were released from 
culture dishes by 5 mM EDTA treatment in PBS and washed three times 
by centrifugation with culture medium. Cells were suspended in PBS con- 
taining CaCI2 (1 mM) and MgC12 (1 mM) and labeled with 1 mCi of 12sI 
in presence of lactoperoxidase  (200 #g/ml) and H202 (0.002%).  For im- 
munoprecipitation labeled or unlabeled cells were extracted  for 20 min at 
4°C with 0.5% Triton X-100 (BDH Chemicals Ltd., Poole, England) in 20 
mM Tris-HC1, pH 7.4,  150 mM NaC1 (TBS)  with 1 mM CaClz,  1 mM 
MgClz,  10 #g/ml leupeptin, 4 #g/ml pepstatin, and 0.1 TIU/ml aprotinin 
(all from Sigma Immunoehemicals,  St.  Louis, MO). After centrlfugation 
at 10,000 g for 10 min, extracts were incubated with the specific antibodies 
for I h at 4°C with gentle agitation. Soluble immunocomplexes were bound 
to protein A-Sepharose beads (Pharmacia, Uppsala, Sweden) and recovered 
by centrifugation.  After washing,  bound material was  einted by boiling 
beads in 1% SDS (Pierce, Rockford, IL) and analyzed by SDS-PAGE (6%) 
in the absence of reducing agents (Laemmli,  1970).  The radioactive pro- 
teins were visualized by fluorography  (Chamberlain, 1979). In the experi- 
ment shown in Fig. 4 A the immunoprecipitation was performed after pro- 
tein denaturation with SDS.  In this case  cells  were  extracted  in TBS 
containing 0.1% SDS and boiled for 3 min. After cooling, Triton X-100 was 
added to the final concentration of 0.5%  and the sample was subjected  to 
immunoprecipitation as described above. 
Western Blotting 
Human adult tissues were obtained at autopsies taken within 2-4 h from 
death. The samples were homogenized and immediately boiled in 2% SDS, 
100 mM Tris-HC1, pH 6.8, 10 mM EDTA, and 10% glycerol. After protein 
determination,  5%  beta  mereaptoethanol and  bromopbenol blue  were 
added and samples were boiled again.  At least three independent samples 
were analyzed for each tissue.  For Western blotting, 150 •g  of total tissue 
or ceil proteins (per each lane) were separated by SDS-PAGE and trans- 
ferred to nitrocellulose sheets  by standard procedure.  After transfer to 
nitrocellulose,  strips were  cut,  washed  with TBS with 0.1% Tween  20 
(TBS/Tween),  and incubated in the same buffer with 2% BSA and 0.3% 
gelatin.  Strips were then incubated with affinity-purified antibodies to/31B 
(1  ~g/ml  for  15  h  at  4°C)  in  TBS/Tween,  washed  three  times  with 
TBS/Tween,  and incubated for 2 h at room temperature with ~2SI-labeled 
antibodies to rabbit IgG (Amersham Corp., Arlington Heights,  IL).  Blots 
were then extensively washed, dried and exposed to X-ray films for 40-96 h 
at -70°C. 
Affinity Chromatography on l~'bronectin-Sepharose 
The fibronectin-Sepharose matrix was a generous gift of Dr.  R.  Pytela 
(Department of Medicine,  University of California San Francisco,  San 
Francisco, CA) and was prepared as described (Pytela et al.,  1987). 
CHO cells transfected  with the BIB subunit were collected  in PBS and 
radiolabeled with 12sI  as described above.  Labeled cells were  extracted 
with 1 ml of 20 mM Tris-HCl,  pH 7.4, 150 mM NaC1 (TBS) with 200 mM 
/3-octylglucoside,  1 mM CaCI2,  1 mM MgC12,  1 mM MnC12, 10 #g/ml 
leupeptin, 4 #g/ml pepstatin, and 0.1 TIU/ml apmtinin. After centrifugation 
at  10,000  g,  soluble  materiai  was  chromatographed on  the  fibronec- 
tin-Sepharose column. After washing with 5 Vol of 50 mM/3-octylgluco- 
side in TBS with cations, the column was eluted sequentially with: (a) TBS, 
50 mM/3-octylglucoside 1 mg/ml of GRGDSP peptide;  (b) 10 mM EDTA 
in TBS octylglucoside.  In some experiments GRGESP peptide was used as 
control. GRGDSP and GRGESP synthetic  peptides were synthesized  by 
Drs. L. Lozzi and P. Neff (University of Siena,  Siena,  Italy).  The column 
flow was kept at 40 ml/h through all steps of the chromatography.  100-#1 
aliquots from each fraction were analyzed by SDS-PAGE under non reduc- 
ing conditions. 
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CHO cells transfected with either BIB or B1A cDNAs were plated on glass 
coverslips pre-coated with human plasma fibronectin (10 t~g/ml). To im- 
prove cell spreading cells were starved for 48 h in serum-free HAM F12 
medium and treated during the last 12 h with transforming growth factor 
B 5 ng/ml (TGF-B,  Sigma Immunochemicals). Under  these conditions virtu- 
ally all cells showed well organized stress fibers and focal contacts. Cells 
were fixed for 15 min with 4% paraformaldehyde in PBS at room tempera- 
ture, washed in 20 mM Tris-HC1, pH 7.3, 150 mM sodium chloride (TBS) 
and permeabilized for 1 min in TBS containing 0.5% Triton X-100 at 4°C. 
The BIB and B1A integrins were localized with the ALA5 mAb specific for 
the human BI (1/100 dilution of ascitic fluid). The endogenous CHO cell 
B1A was localized with the mAh 7E2 specific for the hamster B1 (generous 
gift of Rudy Juliano,  University of North Carolina,  Chapel  Hill, NC). 
Bound antibodies were then visualized by appropriate rhodamine-labeled 
secondary antibodies (KPL). In some experiments cells were double labeled 
with  fluorescein-conjugated  phalloidin  (Sigma  Chemic  GmbH,  Tauf- 
kirchen, Germany). Cells were examined with a fluorescence microscope 
(BH-2; Olympus Corp., Lake Success, NY) and pictures were taken on 400 
ASA Kodak black and white film exposed to 1,600 ASA (Eastman Kodak 
Co., Rochester, NY). Interference reflection microscopy was performed on 
a  Zeiss  photomicroscope  equipped  with the  appropriate  optical  system 
(Carl Zeiss, Oberkochen, Germany). 
Results 
Expression of  [311] in Human Tissues 
and in Cultured Cells 
To analyze the expression of the BIB protein we developed 
an antiserum directed to a synthetic peptide reproducing the 
last 11 COOH-terminal amino acids unique of this molecule 
(see Materials and Methods and Fig.  1).  The specificity of 
this antiserum was demonstrated by immunoprecipitation of 
CHO cells transfected  with the full length cDNA for the BIB 
molecule (see below and Fig.  3). 
To  investigate  the  expression  of the  BIB,  human  tissue 
samples were extracted with SDS and processed for Western 
blot analysis.  As shown in Fig.  2  A,  an intensely  positive 
band with a molecular mass of 130 kD  (reduced)  was de- 
tected  in  extracts  from skin  and  liver,  while a  barely  ap- 
preciable signal was present in cardiac and skeletal muscle 
extracts.  At the same time no reaction was observable with 
extracts  from kidney,  brain,  or aortic media.  All  samples 
gave a strong positive reaction with antibodies to the classi- 
cal B  IA (Fig. 2 B). The positive reaction of skin and liver 
with BIB antibody was confirmed by analysis of cultured 
cells. As shown in Fig. 2  C, cultured human keratinocytes 
were clearly positive, while no reaction was observed with 
cultures of skin fibroblasts, smooth muscle, or endothelial 
ceils. Thus, keratinocytes are the BIB-positive cell type in 
the skin. Furthermore, the HepG2 hepatoma cell line was 
positive indicating that the reaction in the liver is likely to 
be due to hepatocytes. In addition to these cells, an astrocy- 
toma cell line, produced by immortalization of human fetal 
astrocytes (Balabanov et al.,  1990),  was found to express 
BIB (Fig. 2  C). 
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Figure 1. Cytoplasmic domain sequence of B 1A and/3113 integrins. 
The B1 molecule is schematically represented with the extracellu- 
lar and cytoplasmic domains (filled rectangles) and transmembrane 
(open rectangle) domain. The sequence of the B1A and BIB cyto- 
plasmic domains is indicated with the one-letter code and the boxed 
area represent the unique regions of the two proteins (Argraves et 
al.,  1987; Altruda et al.,  1990). 
Figure 2. Analysis of B1B expression in human tissues and cultured 
cells by Western blotting. Human tissue samples or cells were ex- 
tracted with boiling SDS and 150/,g of protein were separated on 
a 7.5 % polyacrylamide gel under reducing conditions. After trans- 
fer to a  nitrocellulose filters, BIB and B1A were identified with 
affinity purified antibodies to the COOH-terminal sequence of the 
proteins followed by t2SI-labeled  secondary antibodies. A  and B 
show human tissue extracts stained for BIB (A) and B1A (B): (lanes 
a) kidney; (lanes b) brain; (lanes c) aortic media; (lanes d) skin; 
(lanes e) liver; (lanes  f) cardiac muscle; and (lanes g) skeletal mus- 
cle.  C and D  show cultured cell extracts stained for BIB (C) and 
B1A (D): (lanes a) astrocytoma cell line; (lanes b) keratinocytes; 
(lanes c)  HepG-2 hepatoma cell line; (lanes d)  skin fibroblasts; 
(lanes e) smooth muscle cells; and (lanes  f) endothelial cells. The 
doublets of bands in D is likely to be due to the presence of a con- 
siderable amount of immature B1A in cultured cells (see Rossino 
et al.,  1991). 
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Cells were surface labeled with laetoperoxidase catalyzed ~25I io- 
dination and after detergent extraction integrin complexes were im- 
munoprecipitated with specific antibodies. Radioactive  proteins are 
visualized by fluorography after separation in 6% polyacrylamide 
gels under nonreducing conditions. CliO cells transfected with the 
/31B eDNA (clone 18/24) immunoprecipitated with: (lane a) poly- 
clonal antibody for the BIb. peptide; and (lane b) mAb AlAS to hu- 
man  /31. Untransfected  control  CHO  cells  immunoprecipitated 
with: (lane c) polyclonal antibody specific for the/31A peptide; and 
(lane d) mAb A1A5 to human/31. Immunoprecipitation with poly- 
clonal antibody specific for the/31B peptide from/31B transfected 
CHO (clone 18.24) (lane e) and untransfected CHO (lane f). The 
position of 13 (120 kD) and c~ (150 kD) subunits is indicated. 
Surface Expression and Binding Properties of  B1B 
in Transfected CHO Cells 
To analyze the functional properties of the/31B we trans- 
fected CHO cells with the full-length eDNA for the human 
/3lB. These cells do express the classical but not the variant 
form of/31 (see below and Fig. 3). The transfected protein 
was identified by means of  AIA5 mAb that recognize human- 
specific epitopes common to/31B and/31A, but does not react 
with/31 of CHO cells (hamster) (see Fig. 3, lanes b and d). 
Conversely the endogenous CHO/31A was  identified with 
polyclonal antibodies to a peptide representing the COOH- 
terminal sequence specific of the classical/31A and absent in 
the/31B form (see Materials and Methods). 
Transfected CHO cells were selected by neomycin resis- 
tance and  clones expressing /31B at the cell surface were 
identified by immunofluorescence and FACS analysis. 
Transfected cells were labeled with lactoperoxidase catha- 
lyzed surface radioiodination followed by immunoprecipita- 
tion.  The  human-specific  mAb  A1A5  reacted  only  with 
transfected cells and identified two bands of 150- and 120-kD 
co-migrating,  respectively,  with  the  c~s  and  /31  proteins 
precipitated with the antibodies to the/3LA (Fig. 3, lanes a 
and b). Thus the/3 IB is appropriately exported at the cell sur- 
face in association with hamster ot subunits.  The/31B was 
also specifically recognized by the polyclonal antibodies to 
the synthetic peptide specific of the BIB. These antibodies, 
in fact, reacted only with/31B transfected cells, and failed to 
recognize the classical B1A subunit (Fig. 3, lanes e and f). 
To test the ability of the/31B to form a fibronectin-binding 
receptor,  t25I-labeled extract of/31B transfected cells were 
chromatographed through a fibronectin column. Elution of 
bound material with GRGDSP peptide yielded two bands of 
150 and 120 kD (Fig. 4). Further elution of the column with 
Figure 4. Binding of/31B inte- 
grin complexes to fibronectin 
affinity matrix. Detergent ex- 
tracts from ~25I-labeled CHO 
cells  expressing  human  /~IB 
molecule (clone  18.24) were 
chromatographed  through  a 
fibronectin-Sepharose  column. 
After extensive  washing, botmd 
material was eluted with buf- 
fer containing 1 mg/ml of the 
GRGDSP peptide or 10 mM 
EDTA. Aliquots of each frac- 
tions (1-15) were analyzed by 
SDS-PAGE  under  non-re- 
ducing conditions. The wash 
fractions prior to elution with 
GRGDSP  were  immunopre- 
cipitated with antibodies to/31 
(lane  a).  The  bound  and 
eluted fractions (1-9) were im- 
munoprecipitated with: poly- 
clonal antibodies to the classi- 
cal/31 (lane b); mAb AlAS to 
human  /31  to  identify  the 
transfected/31B (lane c); poly- 
clonal antibodies to t~3 (lane 
d);  and tx5 (lane e) integrin 
subunits. 
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et al., 1987), did not yield any further material (Fig. 4). The 
positive fractions were pooled and probed with antibodies 
for the two B 1 forms and for ot subunits.  AS shown in Fig. 
4  both B1A and BIB are present in the eluted material to- 
gether with or5. A small amount of or3 subunit was also de- 
tected consistently with the ability of this molecule to bind 
the RGD site of fibronectin (Elites et al.,  1991).  The BIB- 
containing complex can not be eluted with GRGESP peptide 
(not shown). These results indicate, thus, that BIB forms het- 
erodimeric complexes with integrin ot subunits and it binds 
fibronectin in an RGD-dependent manner. 
The association of BIB with ct subunits and expression at 
the cell surface was further demonstrated in the astrocytoma 
cell line that normally express this variant. These cells were 
surface labeled with ~2q and immunoprecipitated with B1A 
or  BIB  antibodies.  AS  shown  in  Fig.  5,  both  antibodies 
precipitated a band of 130 kD (reduced). The intensity of the 
BIB band is  ~30%  than that of the B1A as determined by 
Figure 5.  Immunoprecipitation of BIB integrin from human as- 
trocytoma  ceils  and  association  with  tx  subunits.  (A)  125I sur- 
face-labeled astrocytoma cells were extracted with 0.1% SDS, and 
after re-naturation with Triton X-IO0, the sample was divided in two 
identical aliquots and immunoprecipitated with polyclonal antibod- 
ies to BIB (lane a) or B1A (lane b) cytoplasmic peptides. Radioac- 
tive proteins are visualized by fluorography after separation by 
SDS-PAGE under reducing conditions. (B) To analyze the associa- 
tion of BIB with c~ subunits, integrin complexes were immunopre- 
cipitated from unlabeled astrocytoma cells under standard condi- 
tions using: (lane a) mAb  102DF7 to B1; (lane b) mAb TS2/7 
against al; (lane c and d) polyclonal antibodies to c~5; and (lane 
e) anti-/53 antibody as a negative control. The immunoprecipitated 
material was separated by SDS-PAGE, transferred to nitrocellulose 
filters and probed with affinity purified antibodies to BIB cytoplas- 
mic peptide followed  by radiolabeled secondary antibodies. The au- 
toradiography  of the Western blot is shown. Note that the BIB 
subunit is precipitated in association with both c¢1 (lane b) and c~5 
(lane c and d) subunits under non-dissociating conditions, but it is 
not precipitated by 83 antibodies (lane e). (C) To demonstrate the 
expression of the c~l//~l and ot51B1 integrin complexes on astro- 
cytoma  cells,  ~2~I-labeled cells  were immunoprecipitated under 
non dissociating conditions (Triton X-100 0,5%) with the mAb 
TS2/7 to txl (lane a) and polyclonal antibody to ct5 (lane b). Radio- 
active proteins are visualized by fluorography after separation by 
SDS-PAGE under non-reducing conditions. 
densitometric analysis. Assuming a comparable efficiency  of 
the two antibodies, the BIB represents about one third of the 
total  B1A  in  these  cells.  To test  the  association  with  ct 
subunits, integrin complexes were first immunoprecipitated 
with a-specific antibodies from unlabeled cell extracts, and 
after SDS-PAGE and Western blotting,  were probed with 
BIB antibodies. As shown in Fig. 5, BIB was found in associ- 
ation with both ctl and or5. 
In conclusion these experiments indicate that the BIB mol- 
ecule associates with ct subunits, is correctly  processed at the 
cell  surface  and  binds  fibronectin  in  a  RGD-dependent 
manner. 
Immunofluorescence Localization  of  BIB 
in Transfected Cells 
To investigate the subcellular localization of the B IB in trans* 
fected  cells,  immunofluorescence  experiments  were  per- 
formed. CHO cells plated on fibronectin coated dishes were 
starved in serum-free medium and treated with TGF-B as de- 
scribed in Materials and Methods.  This treatment was re- 
quired to obtain maximal organization of actin stress fibers 
and focal adhesions. 
Analysis of transfected cells showed that the BIB molecule 
was uniformly distributed at the cell surface and did not con- 
centrate at focal adhesions nor it co-localized with  stress 
fiber ends (Fig. 6). Even in cells fully spread on the substra- 
tum with well organized actin stress fibers BIB was evenly 
distributed on the cell surface (Fig. 6, d and e). The uniform 
distribution of  g/1B  was also observed in cells not treated with 
TGF-B and grown in the presence of serum and identical 
results were obtained with three independent clones (18.24, 
18.6, 18.2) of BIB transfected CHO cells. Moreover, in BIB 
transfected cells, the endogenous hamster B1A localized to 
focal contacts (not shown), indicating that integrins in these 
cells retain the ability to cluster at cell substratum contacts. 
To further investigate this  point we analyzed CHO  cells 
transfected with human B1A. As shown in Fig. 7 the classi- 
cal B1A was organized in patches and streaks co-localized 
with actin stress  fibers and corresponding to interference 
reflection black areas (Fig. 7). The inability of BIB to form 
clusters at cell-substratum contacts was also demonstrated 
in the astrocytoma cell line that constitutively express this 
protein (not shown). 
Discussion 
We have investigated the expression and functional proper- 
ties  of a  previously  identified variant bf the  integrin  /51 
subunit. The data indicate that the variant protein (BIB) be- 
haves similarly to the classical B1A in terms of association 
with ot subunits and fibronectin binding but it has a restricted 
tissue expression and does not localize at focal contacts with 
the substratum. 
We have originally identified the BIB at the eDNA level 
and the data reported here establish the existence of the B 1B 
as protein molecule. The B1B eDNA most likely originate 
by premature termination of the transcription within the last 
intron of the B1 gene; in the mature BIB transcript the re- 
tained  intronic  sequence  code  for  the  unique  COOH- 
terminal tail of BIB (Altruda et al., 1990). The existence of 
the B1B protein in a restricted number of  cell types, as shown 
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cence  localization  of human 
/31B  integrin  in  transfected 
CHO  cells.  Cells  expressing 
the  transfected  human  ~IB 
(clone  18.24)  were plated on 
fibronectin-coated  glass  cov- 
erslips and treated with TGF-~ 
in serum-free medium as de- 
scribed in Materials and Meth- 
ods.  Cells  were  fixed  with 
paraformaldehyde,  permeabil- 
ized with detergent, and then 
incubated  with the monoclonal 
antibody  A1A5 followed  by 
RITC-labeled secondary anti- 
body to localize/3113 (a, d, f, 
and  h).  Actin  fibers  were 
visualized  with  Fl'I~-phalloi- 
din (b, e, and g) and interfer- 
ence reflection microscopy was 
used to identify focal adhesion 
sites (c and i). Arrowhead in c 
points to dark IRM streaks co- 
incident  with  actin  fibers  (b) 
and showing  no obvious clus- 
tering of~lB (a). Note also the 
diffuse  staining  for /$1B in  d 
and  f  showing  no  codistri- 
bution with actin fibers (e and 
g). The cell in d and e is a giant 
polyploid  cell  (normal-size 
cells are visible at the corners). 
The perinuclear staining  with 
~IB antibodies  (a, d,f, and h) 
is  probably  due  to  BIB  ac- 
cumulated in the Golgi appa- 
ratus.  Bar,  5 /zm. 
in this paper, clearly demonstrates that the message is trans- 
lated and strongly argues against the possibility that the BIB 
mRNA  is  generated  by  an  incorrect  transcription  mech- 
anism. 
The/~IB and the/~IA are identical except for the COOH- 
terminal portion corresponding  to the cytoplasmic domain. 
The cytoplasmic domain of the/31A  is 47-amino acid  (aa)  2 
residues  long,  assuming  Lys752  as  first residue  out of the 
lipid bilayer (Argraves et al.,  1987).  The last 21 aa residues 
2. Abbreviation  used in this paper:  aa, amino acid. 
of this domain are replaced in the/~IB by a new, nonhomolo- 
gous, sequence of 12 aa (see Fig.  1). Theoretical considera- 
tion  suggests  that  this  alteration  should  cause  significant 
functional differences in the protein.  In fact, the amino acid 
sequence of the cytoplasmic domain of the/~ 1A is rigorously 
conserved  during  evolution.  Comparative  analysis  of  the 
Xenopus  and  human  proteins  indicate  that  the  last  47-aa 
COOH-terminal  residues  are  identical  in the two  species, 
while the remaining portion is 80% homologous (DeSimone 
et al.,  1988).  This indicates  that molecular interactions  of 
this  domain pose rigorous  structural  constraints. 
The Journal of Cell Biology, Volume  121, 1993  176 Figure 7. Immunofluorescence localization of human BIA integrin in transfected CHO ceils. Cells expressing the transfected human BLA 
(clone 8.37) were plated on fibronectin-coated glass coverslips and treated with TGF-B in serum-free medium as described in Materials 
and Methods. Cells were fixed with paraformaldehyde, permeabilized with detergent and incubated with the mAb A1A5 followed by RITC- 
labeled secondary antibody to localize human B  IA (a and d). Actin fibers were visualized with FITC-phalloidin (b) and interference reflec- 
tion microscopy was used to identify focal adhesion sites (c). ~/1A is clustered in streaks (arrowheads in a) coincident with actin fibers 
(b) and with dark IRM areas (c). Bar, 5 #m. 
The data presented here indicate that the new cytoplasmic 
sequence does not affect the ability of the/31B to form func- 
tional heterodimers with ct subunits. In fact, the transfected 
/31B, as well as that normally expressed in a human astrocy- 
toma cell line, associate with ot subunits to form complexes 
that are expressed at the cell surface. Moreover, in associa- 
tion with or5, B 1B form a functional complex capable of  bind- 
ing fibronectin in a RGD-dependent manner. Previous data 
from other laboratories have shown that an artificial deletion 
mutant of/31 molecule lacking the entire cytoplasmic do- 
main shows normal capacity to associate with ct subunit and 
to bind fibronectin (Hayashi et al., 1990; Marcantonio et al., 
1990). Our data further indicate that the new sequence pres- 
ent in BIB does not confer specific properties to the molecule 
in these respects. 
The/31B molecule, however, is functionally different from 
the/31A with respect to its subcellular localization. The vari- 
ant form, in fact, does not localize at focal contacts in adher- 
ent ceils, but it remains diffuse over the whole cell surface. 
This suggests that the/31B differ in its ability to interact with 
cytoplasmic components. The t31A is normally concentrated 
in focal contacts, specialized sites of cell-matrix adhesion 
(Burridge et al., 1988). At these sites,/31A co-localizes with 
vinculin, talin, and ot actinin, three cytoskeletal proteins that 
are part of the molecular machinery connecting integrins 
with actin microfilaments.  The ability to localize at focal 
contacts  is  lost  if  the  cytoplasmic  domain  of  /31A  is 
artificially deleted (Hayashi et al., 1990; Marcantonio et al., 
1990). In addition, analysis of several different deletions in 
this region of the molecule, suggests the existence of three 
sites important for focal contact localization (Hayashi et al., 
1990; Marcantonio et al.,  1990; Reszka et al.,  1992). One 
is within residues 764-774 close to the lipid bilayer and the 
other two are further down-stream at residues 785-788 and 
797-800 (Reszka et al.,  1992). According to these data the 
/31B still retain the first site required for focal contact local- 
ization (residues 764-774), but is missing the two COOH- 
terminal ones, which are replaced by the new sequence. The 
presence of the new sequence abolishes the localization of 
/31B at  focal contacts presumably altering  the interaction 
with cytoskeletal component such as vinculin, talin, and al- 
pha actinin. The existence of a  naturally occurring variant 
of 131 with these properties poses the question of its possible 
role in cell adhesion. One intriguing possibility is that/31B 
act as a dominant negative regulator of cell adhesion. 
An important finding is that/31B expression is restricted 
to certain cell types. This conclusion is based on a Western 
blot analysis of human tissue samples and of cultured cell 
lines with antibodies to a  synthetic peptide specific for the 
/3lB. In particular keratinocytes, hepatoma, and astrocytoma 
cells are positive, while several other cell types and tissues 
do not express detectable levels of the protein. The expres- 
sion of/31B in positive cells reaches considerable levels. In 
fact, in the astrocytoma cell line the/31B is •30%  of  the clas- 
sical/31A. So far we have not detected cell types expressing 
only the t31B and lacking the/31A form. Previous analysis in- 
dicated expression of the/31B in several cell type including 
endothelial cells, lymphoma, hepatoma, and neuroblastoma 
cell lines (Altruda et al.,  1990). This conclusion was based 
on the detection of the 131B transcript with a reverse PCR as- 
say. This technique is very sensitive but is poorly, if at all, 
quantitative.  Using antibodies we now find that among the 
cell lines previously tested only hepatoma cells express the 
/31B protein  at  detectable  level,  while  endothelial,  lym- 
phoma, and neuroblastoma ceils are negative. This indicates 
that, while very low levels of the 131B mRNA are present in 
most cells,  the  protein  is  accumulated only in  some  cell 
types. 
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